Catalyst Wire Dossier Catalyst Wire Dossier

Setrobuvir

setrobuvir · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Setrobuvir, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C [Phase 2]

See pricing